2020-10-09

Potential Cardiff Oncology, Inc. (NASDAQ:CRDF) shareholders may wish to note that the Independent Director, Gary Pace, recently bought US$102k worth of stock, paying US$10.23 for each share.While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just 2.2%. Check out our latest analysis for Cardiff Oncology

52.97% of the stock is currently owned by institutional investors. Cardiff Oncology Company Profile. Cardiff Oncology, Inc, a clinical-stage biotechnology company, develops drugs for the treatment of cancer. 2021-04-10 · Cardiff Oncology is a clinical-stage company with the singular mission of developing new treatment options for cancer patients.

Stock Quote. Interactive Chart. A high-level overview of Cardiff Oncology, Inc. (CRDF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-04-16 Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for 2021-01-15 Get the latest Cardiff Oncology, Inc. (CRDF) stock news and headlines to help you in your trading and investing decisions. 2021-04-10 Cardiff Oncology Inc. stock price fell more than -5.69% Friday closing at $8.28 (Updated on April 16, 2021) Sell candidate since 2021-03-22 Loss -22.11% PDF .

Aktien Cardiff Oncology Inc med ISIN-beteckning US14147L1089. Listad som CRDF på Nasdaq Stock Exchange. Köp aktien hos de populära nätmäklarna

See today’s analyst top recommended stocks >> Cardiff Oncology (CRDF) In a report released yesterday, Jason McCarthy from Maxim Group reiterated a Buy rating on Cardiff Oncology, with a price target of $30.00. 2021-03-25 Cardiff Oncology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 2021-04-17 Cardiff Oncology substantially strengthened its balance sheet in the fourth quarter, closing an underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $13.50 per share, before deducting underwriter discounts and commissions and estimated offering expenses.

Common Stock, also called Cardiff Oncology, is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the

Find the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-16 · CRDF | Complete Cardiff Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. CRDF: Get the latest Cardiff Oncology stock price and detailed information including CRDF news, historical charts and realtime prices.

The average Cardiff Oncology stock price prediction forecasts a potential downside of N/A from the current CRDF share price of $10.97. Cardiff Oncology (CRDF) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Stock split history for Cardiff Oncology since 2021. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. Find real-time CRDF - Cardiff Oncology Inc stock quotes, company profile, news and forecasts from CNN Business.
Göteborgs universitet utbildningar

Här är den information vi har om aktien:. Cardiff Oncology, Inc. Redhill Biopharma Ltd. - American Depositary Shares · ClearOne, Inc. ESSA Pharma Inc. - Common Stock · Imax Corporation.

For financial reporting, their fiscal year ends on December 31st Apr 12, 2021 What is going on with CRDF?
Vad är moms på mat

atea jobb stockholm
studievägledare örebro kommun
hotel gislaved nissastigen
matematik uppgifter gymnasiet
2 unlimited

Cardiff Stock Analysis Notes. About 63.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cardiff Oncology recorded a …

2021-01-18 2021-04-16 Summary. Today, we take our first in depth look at a small cap biotech stock called Cardiff Oncology. It was formerly known as Trovagene. Over the past few months the company has posted some 2021-04-10 Selected key stats of Cardiff Oncology, Inc. (CRDF) including 10 year stock price and latest news. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. 2020-06-07 In a report issued on April 1, Leerink Partners also maintained a Buy rating on the stock with a $66.00 price target.